Cecal Intubation Time in Colonoscopy: Prospective Clinical Trial
NCT ID: NCT03002662
Last Updated: 2017-08-29
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
1000 participants
OBSERVATIONAL
2016-12-31
2017-09-15
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Effect of the Abdominal Corset on Colonoscopy
NCT03128645
Factors Predict Difficult Colonoscopy Before the Procedure: Prospective Registry Study
NCT06151275
A Study on a New Indicator for Assessing the Difficulty of Colonoscopy Insertion and Its Related Factors
NCT07228715
Effect of Discontinuing Propofol After Cecal Intubation on Patient's Psychomotor Recovery Following Colonoscopy
NCT07168135
Difficult Colonoscopy and Personality Traits
NCT06531226
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
BMI <18.5 underweight (Group 1)
BMI was calculated as weight in kilograms divided by the square of height in meters. BMI \<18.5 underweight (Group 1)
colonoscopy
BMİ: 18.5 - 24.9 normal weight (Group 2)
BMI was calculated as weight in kilograms divided by the square of height in meters. BMİ: 18.5 - 24.9 normal weight (Group 2)
colonoscopy
BMİ: 25- 29.9 overweight (Group 3)
BMI was calculated as weight in kilograms divided by the square of height in meters. BMİ: 25- 29.9 overweight (Group 3)
colonoscopy
BMİ>30 obese (Group 4)
BMI was calculated as weight in kilograms divided by the square of height in meters. BMİ\>30 obese (Group 4)
colonoscopy
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
colonoscopy
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
2. Failure of cecum intubation
3. Inflammatory bowel disease
4. Colectomy story
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Kartal Kosuyolu Yuksek Ihtisas Education and Research Hospital
OTHER_GOV
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Ebubekir Gündeş
Gastroenterogical Surgery
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Eagle Run High Special Education and Research Hospital
Istanbul, , Turkey (Türkiye)
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2016.5/8-19
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.